Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Business
·
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Business
America Caught World Cup Fever. His Job Is to Capitalize on It.
Don Garber, the M.L.S. commissioner, has been planning for this moment for eight years.
CitrixNews Staff
·
7 hours ago
Business
The Paramount-WBD merger: bad news for Hollywood, great news for Tennessee? | Dave Schilling
Yet more consolidation means one less studio, inevitable redundancies and a blow to this city’s cultural heritageThere a...
CitrixNews Staff
·
8 hours ago
Business
Cuba edges toward breakdown as power cuts and US meddling push society to brink
As country swelters under six-month oil blockade imposed by US, tempers are fraying and unrest is growingWhen Cuba’s nat...
CitrixNews Staff
·
8 hours ago
Business
Andy Burnham considers radical shake-up to cut energy bills
Andy Burnham. Photograph: Tayfun Salcı/ZUMA Press Wire/ShutterstockView image in fullscreenAndy Burnham. Photograph: Ta...
CitrixNews Staff
·
9 hours ago